210 related articles for article (PubMed ID: 1655433)
1. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
Araujo FG; Shepard RM; Remington JS
Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
[TBL] [Abstract][Full Text] [Related]
2. In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii.
Chang HR; Pechère JC
Antimicrob Agents Chemother; 1988 Apr; 32(4):524-9. PubMed ID: 2837140
[TBL] [Abstract][Full Text] [Related]
3. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin and spiramycin induce anti-inflammatory response in human trophoblastic (BeWo) cells infected by Toxoplasma gondii but are able to control infection.
Franco PS; Gomes AO; Barbosa BF; Angeloni MB; Silva NM; Teixeira-Carvalho A; Martins-Filho OA; Silva DA; Mineo JR; Ferro EA
Placenta; 2011 Nov; 32(11):838-44. PubMed ID: 21908042
[TBL] [Abstract][Full Text] [Related]
5. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
Romand S; Bryskier A; Moutot M; Derouin F
J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
[TBL] [Abstract][Full Text] [Related]
6. Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii.
Araujo FG; Guptill DR; Remington JS
Antimicrob Agents Chemother; 1988 May; 32(5):755-7. PubMed ID: 2840017
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of spiramycin in murine models of acute and chronic toxoplasmosis.
Grujić J; Djurković-Djaković O; Nikolić A; Klun I; Bobić B
Int J Antimicrob Agents; 2005 Mar; 25(3):226-30. PubMed ID: 15737517
[TBL] [Abstract][Full Text] [Related]
8. Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in mice.
Chang HR; Rudareanu FC; Pechère JC
J Antimicrob Chemother; 1988 Sep; 22(3):359-61. PubMed ID: 2972671
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the efficacy of azithromycin and pyrimethamine, for treatment of experimental infection of mice with Toxoplasma gondii cystogenic strain].
Lescano SA; Amato Neto V; Chieffi PP; Bezerra RC; Gakiya E; Ferreira CS; Braz LM
Rev Soc Bras Med Trop; 2004; 37(6):460-2. PubMed ID: 15765594
[TBL] [Abstract][Full Text] [Related]
10. Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
Brun-Pascaud M; Chau F; Derouin F; Girard PM
J Antimicrob Chemother; 1998 Mar; 41 Suppl B():57-62. PubMed ID: 9579714
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
Costa IN; Angeloni MB; Santana LA; Barbosa BF; Silva MC; Rodrigues AA; Rostkowsa C; Magalhães PM; Pena JD; Silva DA; Mineo JR; Ferro EA
Placenta; 2009 Oct; 30(10):884-90. PubMed ID: 19703714
[TBL] [Abstract][Full Text] [Related]
12. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
Derouin F
Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro activity of roxithromycin against Toxoplasma gondii in mice.
Luft BJ
Eur J Clin Microbiol; 1987 Aug; 6(4):479-81. PubMed ID: 3665901
[TBL] [Abstract][Full Text] [Related]
14. [In vitro effect of combined traditional Chinese medicine (Changqing capsule) on the tachyzoites of Toxoplasma gondii].
Zhang W; Fang FR; Liu YJ; Yang LD; Luo RY; Gong F; Lu H; Xu XX
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):56-8. PubMed ID: 16866146
[TBL] [Abstract][Full Text] [Related]
15. Ketolide ABT-773 is active against Toxoplasma gondii.
Khan AA; Araujo FG; Craft JC; Remington JS
J Antimicrob Chemother; 2000 Sep; 46(3):489-92. PubMed ID: 10980181
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.
Hagras NA; Allam AF; Farag HF; Osman MM; Shalaby TI; Fawzy Hussein Mogahed NM; Tolba MM; Shehab AY
Exp Parasitol; 2019 Sep; 204():107717. PubMed ID: 31228418
[TBL] [Abstract][Full Text] [Related]
17. Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin.
Pfefferkorn ER; Borotz SE
Antimicrob Agents Chemother; 1994 Jan; 38(1):31-7. PubMed ID: 8141576
[TBL] [Abstract][Full Text] [Related]
18. The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infection.
Araujo FG; Khan AA; Slifer TL; Bryskier A; Remington JS
Antimicrob Agents Chemother; 1997 Oct; 41(10):2137-40. PubMed ID: 9333038
[TBL] [Abstract][Full Text] [Related]
19. Antiparasitic effects of oxymatrine and matrine against Toxoplasma gondii in vitro and in vivo.
Zhang X; Jin L; Cui Z; Zhang C; Wu X; Park H; Quan H; Jin C
Exp Parasitol; 2016 Jun; 165():95-102. PubMed ID: 26993085
[TBL] [Abstract][Full Text] [Related]
20. Azithromycin treatment is able to control the infection by two genotypes of Toxoplasma gondii in human trophoblast BeWo cells.
Ribeiro M; Franco PS; Lopes-Maria JB; Angeloni MB; Barbosa BF; Gomes AO; Castro AS; Silva RJD; Oliveira FC; Milian ICB; Martins-Filho OA; Ietta F; Mineo JR; Ferro EAV
Exp Parasitol; 2017 Oct; 181():111-118. PubMed ID: 28803905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
